Company Search:
Advanced Search
Sponsored Links
Vetoquinol Sa Company Snapshot
Vetoquinol Sa operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Vetoquinol Sa with three other pharmaceutical manufacturers in Europe: Sopharma AD of Bulgaria (2016 sales of 889.52 million Bulgarian Lev [US$490.91 million] ), FAES Farma SA of Spain (228.64 million Euro [US$246.91 million] of which 87% was Speciality Pharmaceuticals), and Dechra Pharmaceuticals PLC which is based in the United Kingdom (£247.56 million [US$308.68 million] of which 76% was European Pharmaceuticals).

Sales Analysis. During the year ended December of 2016, sales at Vetoquinol Sa were 350.40 million Euro (US$378.40 million). This is an increase of 2.3% versus 2015, when the company's sales were 342.61 million Euro. This was the fifth consecutive year of sales increases at Vetoquinol Sa (and since 2011, sales have increased a total of 23%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Vetoquinol Sa
  Stock Performance Chart for Vetoquinol Sa
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 51.66
(Figures in Euro)
1 Week 0.9%   13 Weeks 3.7%  
4 Weeks 11.8%   52 Weeks 45.9%  
Vetoquinol Sa Key Data:
  Ticker: VETO Country: France
  Exchanges: PAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 350,400,000
(Year Ending Jan 2017).
Employees: 2,036
  Currency: Euro Market Cap: 612,548,428
  Fiscal Yr Ends: December Shares Outstanding: 11,857,306
  Share Type: Action Ordinaires Closely Held Shares: 7,945,213
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.